NasdaqGM - Nasdaq Real Time Price USD
Candel Therapeutics, Inc. (CADL)
4.7600
+0.0250
+(0.53%)
At close: April 23 at 4:00:02 PM EDT
5.2500
+0.49
+(10.29%)
Pre-Market: 7:00:20 AM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AGUILAR-CORDOVA ESTUARDO Beneficial Owner of more than 10% of a Class of Security | Sale | Oct 15, 2024 | 6,053,780 |
| AMELLO JASON A Chief Financial Officer | Stock Award(Grant) | Nov 24, 2023 | 222,162 |
| BARONE FRANCESCA Officer | Conversion of Exercise of derivative security | Mar 18, 2025 | 96,527 |
| MANNING PAUL B. Director | Purchase | Dec 16, 2024 | -- |
| NICHOLS WILLIAMS GARRETT Officer | Conversion of Exercise of derivative security | Mar 18, 2025 | 52,493 |
| SCHOCH CHARLES Chief Financial Officer | Sale | Mar 17, 2025 | 38,038 |
| TAK PAUL PETER Chief Executive Officer | Sale | Mar 19, 2025 | 225,740 |
| TYAGARAJAN SESHU Chief Technology Officer | Conversion of Exercise of derivative security | Mar 17, 2025 | 0 |
Related Tickers
CAPR Capricor Therapeutics, Inc.
13.15
-5.33%
ANNX Annexon, Inc.
1.8400
+4.55%
ENSC Ensysce Biosciences, Inc.
3.6700
+96.26%
RZLT Rezolute, Inc.
3.9700
+27.65%
CHRO Channel Therapeutics Corporation
1.3700
-11.61%
DWTX Dogwood Therapeutics, Inc.
5.87
+7.51%
PRTG Portage Biotech Inc.
8.98
-8.92%
SLXN Silexion Therapeutics Corp
1.0300
+43.94%
BCTX BriaCell Therapeutics Corp.
5.43
+1.50%
APVO Aptevo Therapeutics Inc.
0.7400
+6.72%